| P2093 | author name string | Min Huang | |
| | Beverly S Mitchell | |
| | Patrick Lewicki | |
| | Patrick Whang | |
| P2860 | cites work | DNA damage is able to induce senescence in tumor cells in vitro and in vivo. | Q43931306 |
| | Phenotypic differentiation of human breast cancer cells by 1,3 cyclic propanediol phosphate | Q44411089 |
| | CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase | Q45073108 |
| | p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors. | Q46219717 |
| | Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells | Q46709814 |
| | Inhibition of the Phosphoinositide 3-Kinase Pathway Induces a Senescence-like Arrest Mediated by p27Kip1 | Q57562833 |
| | Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition | Q63446341 |
| | Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs | Q73002431 |
| | p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53 | Q77853882 |
| | DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts | Q77905855 |
| | Functional characterization of human mesenchymal stem cell-derived adipocytes | Q79236161 |
| | p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3 | Q79961068 |
| | Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 | Q24328775 |
| | A biomarker that identifies senescent human cells in culture and in aging skin in vivo | Q24562644 |
| | Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2 | Q24646511 |
| | Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26 | Q24653892 |
| | The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation | Q28280958 |
| | Defining the molecular basis of Arf and Hdm2 interactions | Q28507075 |
| | Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis | Q28585867 |
| | mdm2 expression is induced by wild type p53 activity | Q29618316 |
| | Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition | Q30448378 |
| | Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells | Q30771484 |
| | A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity | Q33861971 |
| | Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase. | Q34561130 |
| | Senescence as an anticancer mechanism | Q34579345 |
| | Cellular senescence in cancer and aging | Q34581486 |
| | Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids | Q35014256 |
| | Cellular senescence in cancer treatment: friend or foe? | Q35628579 |
| | Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin. | Q36057264 |
| | Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. | Q36573040 |
| | Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions. | Q36748093 |
| | Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity | Q36907222 |
| | Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 | Q39576878 |
| | Ribosomal protein S7 is both a regulator and a substrate of MDM2 | Q39812243 |
| | Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models. | Q39884462 |
| | Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival | Q39912417 |
| | Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison | Q40095421 |
| | Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption | Q40140550 |
| | Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. | Q40365756 |
| | Caspase-dependent cleavage of carbamoyl phosphate synthetase II during apoptosis | Q40749705 |
| | Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity | Q40841473 |
| | Induction of senescence in human malignant glioma cells by p16INK4A. | Q41098516 |
| | 5'-Deoxy-5'-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines. | Q41361631 |
| | Phase I clinical trial of continuous infusion cyclopentenyl cytosine | Q42275991 |
| | p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis | Q42471323 |
| P433 | issue | 1 | |
| P304 | page(s) | 40-48 | |
| P577 | publication date | 2011-04-04 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53. | |
| P478 | volume | 80 | |